Poland
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 89.29 M
|
Dec. 31, 2023 | USD 208.13 | 0.81% |
|
Poland |
|
2 |
USD 54.63 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
3 |
USD 45.62 M
|
Dec. 31, 2023 | USD 5.15 | -3.61% |
|
Poland |
|
4 |
USD 31.95 M
|
Dec. 31, 2023 | USD 2.85 | 0.09% |
|
Poland |
|
5 |
USD 31.00 M
|
Dec. 31, 2023 | USD 1.23 | 1.32% |
|
Poland |
|
6 |
USD 30.77 M
|
Dec. 31, 2023 | USD 36.63 | -0.24% |
|
Poland |
|
7 |
USD 18.74 M
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
|
8 |
USD 12.92 M
|
Sept. 30, 2024 | USD 58.16 | 0.74% |
|
Poland |
|
9 |
USD 12.75 M
|
Dec. 31, 2023 | USD 0.90 | -1.27% |
|
Poland |
|
10 |
USD 9.49 M
|
Dec. 31, 2023 | USD 5.95 | -0.32% |
|
Poland |
|
11 |
USD 8.91 M
|
Dec. 31, 2023 | USD 2.29 | -0.01% |
|
Poland |
|
12 |
USD 5.35 M
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
13 |
USD 4.25 M
|
Dec. 31, 2023 | USD 5.86 | 3.96% |
|
Poland |
|
14 |
USD 3.65 M
|
Dec. 31, 2023 | USD 40.34 | 2.10% |
|
Poland |
|
15 |
USD 1.15 M
|
Dec. 31, 2023 | USD 1.78 | -1.14% |
|
Poland |
|
16 |
USD 801.09 K
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
|
17 |
USD 407.27 K
|
Dec. 31, 2023 | USD 0.46 | 18.70% |
|
Poland |
|
18 |
USD 340.57 K
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
19 |
USD 32.75 K
|
Dec. 31, 2023 | USD 21.83 | 2.30% |
|
Poland |
The Healthcare company in Poland with the highest Total Non-Current Liabilities is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at USD 89.29 M.
The Healthcare company in Poland with the lowest Total Non-Current Liabilities is Bioceltix S.A. (Warsaw Stock Exchange: BCX.WA) at USD 32.75 K.
The top 10 Healthcare companies in Poland by Total Non-Current Liabilities are NEUCA S.A., Selvita S.A., Centrum Medyczne ENEL-MED S.A., EMC Instytut Medyczny SA, Synthaverse S.A., Voxel S.A., Ryvu Therapeutics S.A., Synektik Spólka Akcyjna, BIOTON S.A. and Celon Pharma S.A..
The bottom 10 Healthcare companies in Poland by Total Non-Current Liabilities are Bioceltix S.A., Captor Therapeutics Spolka Akcyjna, Europejskie Centrum Odszkodowan S.A., Medinice S.A., Genomtec S.A., Scope Fluidics S.A., Medicalgorithmics S.A., Poltreg S.A., Mabion S.A. and Celon Pharma S.A..